Stock report · Delisted · Nasdaq
Synaptogenix Inc (SNPX)
5.82USD Delisted Final close · Aug 29, 2025
SNPX no longer trades. Synaptogenix was delisted from the Nasdaq in August 2025.
All prices on this page are historical. The last trade was on August 29, 2025, at $5.82.
SNPX stock price history
Final trading statistics
- Final close
- $5.82
- Final trading day
- Aug 29, 2025
- Market cap at delisting
- $8.09M
- Shares outstanding
- 1.39M
- Final 52-week range
- $1.84 – $11.98
- Avg. volume (final 3 mo.)
- 1,077,968
- All-time high
- $343.00 · Oct 2021
- All-time low
- $2.00 · Apr 2025
- Return since IPO
- -93.2%
- Beta
- 1.30
- Book value / share
- $3.72
- Price / book
- 1.56
About Synaptogenix Inc
Synaptogenix, Inc. was a biopharmaceutical company focused on a product platform built on Bryostatin-1 for Alzheimer's disease, which was in clinical testing. It was also studying bryostatin for other neurodegenerative and cognitive conditions, such as Fragile X syndrome, multiple sclerosis and Niemann-Pick Type C disease, which had gone through pre-clinical testing. The company changed its name to TAO Synergies Inc. in June 2025. Incorporated in 2012, it was based in New York, New York. Its stock was delisted from the Nasdaq in August 2025, with a final trade on August 29, 2025 at $5.82.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- New York, NY
- Employees
- 4
- IPO date
- December 8, 2020
- Delisted
- August 29, 2025
- SEC CIK
- 1571934
Synaptogenix financials before the delisting
The last 5 fiscal years Synaptogenix reported as a public company, fiscal year ending December.
SNPX revenue and net income
SNPX earnings per share
SNPX annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | −$12.8M | −$10.34 |
| FY2023 | $0.00 | −$6.0M | −$1.73 |
| FY2022 | $0.00 | −$5.5M | −$2.07 |
| FY2021 | $0.00 | −$12.6M | −$2.79 |
| FY2020 | $0.00 | −$14.2M | −$13.22 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Synaptogenix stock FAQ
What happened to Synaptogenix stock?
Synaptogenix was delisted from the Nasdaq in August 2025. The final close was $5.82 on August 29, 2025.
Can I still buy SNPX stock?
No. SNPX is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on August 29, 2025.
What was the last price of SNPX?
SNPX last closed at $5.82 on August 29, 2025, which valued the company at about $8.09M.
How did Synaptogenix do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Synaptogenix reported revenue of $0.00 and net income of −$12.8M.
When did Synaptogenix go public?
Synaptogenix shares started trading on December 8, 2020.
SNPX no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.